GeneDx Holdings Corp. (WGS) Misses Q3 EPS by 46c

GeneDx Holdings Corp. (NASDAQ: WGS) reported Q3 EPS of ($1.64), $0.46 worse than the analyst estimate of ($1.18). Revenue for the quarter came in at $53 million versus the consensus estimate of $52.76 million.

For earnings history and earnings-related data on GeneDx Holdings Corp. (WGS) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Lululemon (LULU) PT Lowered to $115 at Freedom Broker
• Broadcom Limited (AVGO) PT Lowered to $350 at DA Davidson